SCHEMBL6470522

SCHEMBL6470522

CN(C)OB(ON(C)C)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 2/20 0.42
ORAI1 Q96D31 2/20 0.40
ORAI2 Q96SN7 2/20 0.40
ORAI3 Q9BRQ5 2/20 0.40
TRPV6 Q9H1D0 2/20 0.40
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
ENPP2 Q13822 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
PCSK9 Q8NBP7 1/20 0.36
LTA4H P09960 3/20 0.36
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
KMT2A Q03164 2/20 0.33
TSHR P16473 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6250357 0.78 LTA4H (0.33) PCSK9LTA4HKMT2ATSHRALDH1A1
SCHEMBL27871 0.76 TRPV6 (0.44) CA4ORAI1ORAI2ORAI3TRPV6
SCHEMBL28694660 0.73 ORAI1 (0.39) CA4ORAI1ORAI2ORAI3TRPV6
SCHEMBL309077 0.70 CA4 (0.48) CA4ORAI1ORAI2ORAI3TRPV6
SCHEMBL21177785 0.69 MEN1 (0.37) CA4ORAI1ORAI2ORAI3TRPV6
SCHEMBL734634 0.69 CA4 (0.46) CA4ORAI1ORAI2ORAI3TRPV6
Water SCHEMBL27700277 0.69 CA4 (0.46) CA4ORAI1ORAI2ORAI3TRPV6
Ammonia Solution, Strong SCHEMBL28822149 0.69 CA4 (0.46) CA4ORAI1ORAI2ORAI3TRPV6
SCHEMBL9671605 0.68 CA4 (0.40) CA4LTA4HKMT2ATSHRALDH1A1
Trimethylammonium SCHEMBL8966904 0.67 ORAI1 (0.43) CA4ORAI1ORAI2ORAI3TRPV6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9382213-B2 Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase PROMILIAD BIOPHARMA INC. (US) 2016-07-05 US disclosed
US-20150225353-A1 Heterocyclic and Cyclic Analogs of Propargyl-Linked Inhibitors of Dihydrofolate Reductase UNIVERSITY OF CONNECTICUT 2015-08-13 US disclosed
WO-2005049593-A2 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2005-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150225353-A1 Heterocyclic and Cyclic Analogs of Propargyl-Linked Inhibitors of Dihydrofolate Reductase DHFR, DPYD, FOLR1 CA4 4366/4885ORAI1 3317/4885ORAI2 4074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.